NCT02446509

Brief Summary

Bipolar disorder is a debilitating chronic illness characterized by periods of elation and depression. Since deinstitutionalization of the mentally ill over 40 years ago, families have become major caregivers for patients with bipolar disorder . This illness imposes a substantial and chronic burden on family caregivers Despite their persistent stress and burden, these caregivers have been largely ignored. Interventions to help them have been very limited. One comprehensive intervention was developed and implemented by Miklowitz (2008) and has shown to be effective in reducing caregiver depression and improving health outcomes. However, this intervention and is highly complex, long, and was given on an individual basis, significantly raising the cost of the program. One core component of the Miklowitz (2008) intervention is psychoeducation, which provides the fundamental support and information needed to caregivers on an individual basis. In this pilot study, the intervention group will receive 7 weekly psychoeducation sessions. After completion of these sessions in the intervention group, the wait list control group will receive the same weekly sessions. In this study, the investigators plan to test the feasibility and potential efficacy of this specific psychoeducation intervention implemented in a group setting. The investigators will also examine the effects of this psychosocial intervention on biological mechanisms (cortisol and inflammatory biomarkers) and health outcomes. The specific aims are to:

  1. 1.Test the feasibility of implementing a 7-week group psychoeducation program for family caregivers of patients with bipolar disorder by assessing recruitment and retention rates, attendance, satisfaction with the program, and data and sample collection rate.
  2. 2.Explore the effect of the intervention on caregiver outcomes (depression, burden, health status, mental wellbeing, cortisol, interleukin (IL)-1 and IL-6 levels.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2013

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

April 23, 2015

Completed
25 days until next milestone

First Posted

Study publicly available on registry

May 18, 2015

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2019

Completed
Last Updated

November 3, 2020

Status Verified

November 1, 2020

Enrollment Period

6.2 years

First QC Date

April 23, 2015

Last Update Submit

November 2, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in Caregiver Burden as measured by the Burden Assessment Scale at 8 weeks

    Baseline, 8 weeks

  • Change in Caregiver Burden as measured by the Burden Assessment Scale at 16 weeks

    Baseline, 16 weeks

Secondary Outcomes (4)

  • Change in Caregiver Mental Well Being as measured by the Warwick-Edinburgh Mental Well-Being Scale at 8 weeks

    Baseline, 8 weeks

  • Change in Caregiver Mental Well Being as measured by the Warwick-Edinburgh Mental Well-Being Scale at 16 weeks

    Baseline, 16 weeks

  • Change in Caregiver Depression as measured by the Quick Inventory of Depressive Symptomatology Clinician-Rated at 8 weeks

    Baseline, 8 weeks

  • Change in Caregiver Depression as measured by the Quick Inventory of Depressive Symptomatology Clinician-Rated at 16 weeks

    Baseline, 16 weeks

Study Arms (2)

Experimental Group

EXPERIMENTAL

The experimental group will receive a 7-week group psychoeducation intervention. Caregivers will meet once a week for 90-minute sessions in a group setting. Dates and times of the group sessions will be arranged according to the convenience of the subjects. The major content will include the causes of bipolar disorder, signs and symptoms of bipolar disorder, the role of stress and life events, types of medications and what they do, self-management of the disorder, understanding the course of the disorder, genetic and biological predispositions, how the family can help, management of relapse.

Behavioral: Psychoeducation

Wait List Control Group

ACTIVE COMPARATOR

Subjects in the wait list control group will receive the same 7 psychoeducation sessions after the experimental group receives these sessions.

Behavioral: Psychoeducation - Delayed

Interventions

PsychoeducationBEHAVIORAL

Caregivers will meet once a week for 90-minute sessions in a group setting. Dates and times of the group sessions will be arranged according to the convenience of the subjects. The major content will include the causes of bipolar disorder, signs and symptoms of bipolar disorder, the role of stress and life events, types of medications and what they do, self-management of the disorder, understanding the course of the disorder, genetic and biological predispositions, how the family can help, management of relapse.

Experimental Group

The wait list control group will receive the same intervention as the experimental group, but 7 weeks later.

Wait List Control Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • primary family caregiver of a patient with Bipolar Disorder who is age 16 or older;
  • live within a 70 mile radius of the Center for Excellence in Mood Disorders (in the Texas Medical Center)

You may not qualify if:

  • unstable major medical illness;
  • health condition that may impact biomarker levels, e.g. is taking corticosteroids or anti-inflammatory drugs;
  • unable to read, write, or speak English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Texas Health Science Center at Houston School of Nursing

Houston, Texas, 77070, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor - Clinical

Study Record Dates

First Submitted

April 23, 2015

First Posted

May 18, 2015

Study Start

September 1, 2013

Primary Completion

November 1, 2019

Study Completion

November 1, 2019

Last Updated

November 3, 2020

Record last verified: 2020-11

Locations